Reaction

Stoma Site Erythema reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,846 reports · 30 co-occurring drugs

As of the last recalculation, Stoma Site Erythema appears in 1,846 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is CARBIDOPA AND LEVODOPA (PRR 123.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Carbidopa And Levodopa406123.4124.5
Rotigotine11595.596.3
Rivastigmine14694.895.5
Rasagiline Mesylate7680.280.8
Ropinirole9573.574.0
Pramipexole8867.968.3
Levodopa6764.865.2
Amantadine8363.363.6
Teduglutide2016.916.9
Clozapine14113.613.6
Oxazepam2513.313.3
Memantine1512.512.5
Memantine Hydrochloride1512.512.5
Melatonin5712.112.2
Bisacodyl1411.311.3
Lactulose3711.111.1
Meperidine Hydrochloride911.111.1
Lubiprostone910.810.8
Bisacodyl Suppositories1210.510.5
Biscodyl1210.410.4
Mirabegron339.89.8
Mirtazapine698.88.8
Donepezil Hydrochloride268.18.1
Miconazole Nitrate67.87.8
Fesoterodine Fumarate55.25.2
Brinzolamide45.25.2
Linaclotide114.74.7
Suvorexant54.44.4
Droxidopa84.24.2
Pimavanserin Tartrate132.72.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.